RE:RE:RE:June 30 short interest
easy regardless, the generic non-r&d sector are all trading about 3 to 5 times cash flows and so is CXR. No one else in the sector is screaming and we are in that group. The market is discounting all guidance in the sector by 50% or so. It is a show me market and without any catalysts, we sit and wait and don't bother for a while. The current multiples are well below trends and will reverse. As to the shorts, when u factor out Cinven, mgmt stock, Insurance co's, and funds, a 12 plus million short is almost 50% of the available stock. Add the fact that the US exchange is the minor player in the volume and the options market is equally thin, it just does not all add up to BS reporting by an unverified NASDQ system imo.